WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 1'0601 Infant (under 12 months) mortality rate: 492
GDP / capita (US$): 2'6551 Child (under 5 years) mortality rate: 582

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 8'409  8'208  8'009  7'815  7'627  6'186  5'297  3'918 
Births 275  271  265  258  249  189  212  155 
Surviving infants 260  256  250  244  235  176  192  137 
Pop. less than 5 years 1'231  1'195  1'150  1'096  1'029  888  955  626 
Pop. less than 15 years 3'024  2'946  2'874  2'806  2'739  2'653  2'311  1'683 
Female 15-49 years 2'191  2'154  2'113  2'072  2'032  1'492  1'175  872 

Number of reported case

(Click for retrospective incidence data for Tajikistan)
Diphtheria 11  11 
Japanese encephalitis
Measles 16  192  6'897 
Mumps 1'530  1'518  1'441  1'558  428 
Pertussis 56  12  13  935 
Polio* 457 
Rubella 111 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)**
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Tajikistan)
Vaccine year result method % card seen                                                
BCG 2011  98  DHS   91  98  98  97  97  98  99 
DTP1 2011  98  DHS   91  99  98  96  98  95  98 
DTP3 2011  93  DHS   91  97  96  94  96  93  96 
DTP4          96 
IPV1         
HepB_BD          98  98  98  98  96 
HepB3 2011  93  DHS   91  97  96  94  96  93 
Hib3 2011  93  DHS   91  97  96  94  96  93 
JapEnc         
MCV1          98  92  95  98  94  98 
MCV2          98  92  97  96  81  31 
PCV1         
PCV3         
Pol3 2011  92  DHS   91  94  97  96  97  95  98 
Rota1         
Rota_last         
Rubella1          98  92  94 
TT2plus         
PAB         
VAD1          97  99*  98 
YFV          98 
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Tajikistan)
BCG 98  98  97  97  98  98 
DTP1 98  98  96  98  95  88 
DTP3 97  96  94  96  93  83 
HepB3 97  96  94  96  93 
HepB_BD 98  98  98  98  96 
Hib3 97  96  94  96  93 
MCV1 98  92  94  98  94  88 
MCV2 98  92  97  96  95  59 
PCV3
Pol3 94  97  96  97  95  86 
Rota_last

Number of districts in the country 65  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 3-5 days; 6 years; Yes
DT 1 year; Yes
DTwP 16 months; Yes
DTwPHibHepB 2, 3, 4 months; Yes
HepB birth; Yes
IPV 4 months; Yes From September 2015
MR 12 months, 6 years; Yes
OPV birth; 2, 3, 4, 12 months; Yes
Rotavirus 2, 3 months; From January 2015
Td 6, 16, 26, 36, 46, 56 years; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2010-2015  2010-2015  2011-2015  2011-2015  2007-2010  2008-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 66  66  66  65  65  66 

System performance

Total Nº districts in country number 65  66  66  66  65  65  66 
Nº districts with DTP3 coverage >=80% number 65  66  66  66  65  65  60 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  91 
Nº districts with measles (MCV1) coverage >=95% number 65  60  59  59  46  63 
% of districts with MCV1 coverage >=95% From 0 to 100% 100  91  89  89  71  97 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 31    22  34  41  19 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.